Skip to main content
logo
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.120
-0.040 (-3.45%)
At close: Sep 1, 2026, 4:00 PM EDT
1.100
-0.020 (-1.79%)
After-hours: Sep 1, 2026, 5:31 PM EDT

Cocrystal Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
221321181663
Market Cap Growth
40.10%-34.34%17.29%10.34%-74.94%-32.06%
Enterprise Value
2179-12-262
Last Close Price
1.160.982.021.721.957.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
15.322.132.160.660.400.82
P/TBV Ratio
21.402.132.160.660.401.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.280.240.190.070.010.01
Net Debt / Equity Ratio
-0.79-0.87-0.85-0.93-0.93-0.75
Net Debt / EBITDA Ratio
0.080.620.451.172.054.15
Net Debt / FCF Ratio
0.100.670.491.661.714.56
Quick Ratio
1.113.504.568.3531.1438.00
Current Ratio
1.243.684.778.9233.0438.40
Return on Equity (ROE)
-311.68%-111.40%-97.50%-54.54%-66.32%-21.81%
Return on Assets (ROA)
-96.07%-48.66%-49.98%-36.68%-18.86%-13.30%
Return on Capital Employed (ROCE)
-497.30%-120.20%-162.10%-75.60%-45.80%-18.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.47%-65.44%-85.17%-102.64%-244.58%-22.39%
FCF Yield
-35.65%-60.80%-80.25%-84.38%-135.46%-20.16%
Buyback Yield / Dilution
-28.73%-10.97%-5.42%-18.52%-10.58%-60.04%
SEC Filings: 10-K · 10-Q